recycle delay of 1.5 seconds and 4 scans per increment. The data was processed using squared sinebell window function, symmetrized, and displayed in magnitude mode. Multiplicity-edited HSQC experiments were acquired using a 1024 x 256 data matrix, a J C-H value of 145 Hz, which resulted in a multiplicity selection delay of 34 ms, a recycle delay of 1.5 seconds and 16 scans per increment along with GARP decoupling on 13 C during the acquisition time (150 ms). The data was processed using a π/2
shifted squared sine window function and displayed with the CH/CH 3 signals phased positive and the CH 2 signals phased negative. Acquisition parameters for 13 C-15 N decoupling experiments were similar to those listed above for a standard 13 C NMR experiment with the exception of an additional 200 µs pulse applied to the 15 N channel during acquisition using the WALTZ-16 pulse scheme.
HPLC Analysis and purification of the nucleoside adducts were conducted on a Beckman HPLC gradient system with a diode array UV detector monitoring at 260 nm using a Phenomenex Luna 5 µm C18(2) 100A columns (4.6 x 250 mm, 5 µm) at a 1.0 mL min -1 for analysis and (250 x 10 mm, 5 µm) at a 3 mL min -1 for purification. MS instrument parameters were optimized by infusing the crosslink 1 with the syringe pump into the MS source through a mixing tee at a flow rate of 0.025 mL/min. The LC solvent (1:1 A/B) flowed at 0.15 mL/min. Other MS parameters were optimized to achieve maximum signal intensity. Liquid chromatography was carried out at 45° C at a flow of to 0.2 µL min -1 using gradient mixture of 1:99 CH 3 CN in 10 mM ammonium acetate buffer (solvent A) and 90:10 CH 3 CN in 10 mM ammonium acetate buffer (solvent B). The gradient program began at 1% B, then a 2 min linear gradient to 10% B, a 3 min linear gradient to 50% B, a 2 min linear gradient to 100% B, then isocratic at 100% B for 0.5 min, then a 0.5 min linear gradient back to 1% B, followed by a 3 min isocratic period to allow the column to re-equilibrate to the starting conditions (11 min, UPLC gradient I). Samples (10 µL) were injected through a 10 µL injection loop into a six-port switching valve injector that diverted the column eluent to waste for the first 2.0 min of UPLC gradient I.
Peptide cross-link analysis. The mass spectrometer was operated in positive ionization mode. LTQ MS parameters were optimized for maximum response during infusion of a standard solution of the synthetic AcAVAGKAGAR peptide, so that some parameters may have varied slightly from experiment to experiment. Typically, the tune parameters were as follows: N 2 sheath gas, 60 psi; N 2 auxiliary gas, 172.3, 169.5, 155.7, 143.9, 143.8, 140.7, 127.6, 127.1, 125.3, 120.1, 65.6, 51.9, 51.7, 50.1, 46.7, 38.1, 30.6, 28.6, 22.6, 22.2, 18 .4.
N2-acetyl-N6-[N-((9H-fluoren-9-ylmethyloxy)carbonyl)-L-alanyl]-L-lysine ((S)-2).

N2-acetyl-N6-[N-((9H-fluoren-9-ylmethyloxy)carbonyl)-D-alanyl]-L-lysine ((R)-2).
The diastereomeric (R)-2 was synthesized from FMOC-D-Ala in 78 % yield using the same procedure as for 6, 174.3, 173.4, 158.2, 145.4, 145.2, 142.6, 128.8, 128.2, 126.2, 121.0, 67.9, 55.9, 53.8, 52.7, 52.2, 43.7, 39.9, 32.1, 29.9, 24.1, 22.3, 18 .5. C and monitored by analytical HPLC using gradient I or II. After 3 days, the reaction mixture was cooled and concentrated in vacuo using a centrifugal evaporator. The residue was dissolved in 5 % aqueous acetic acid (1.5 mL) and stirred at room temperature. After 15 min, the reaction mixture separated into an aqueous and oil layers; the mixture was stirred for 1 h, then the water layer was separated and neutralized to pH 7.0 with 1 % NaOH. The product mixture was filtered through a 0.45 µm filter cartridge, rinsed with water (3 × 1 mL), and lyophilized. The resulting solid residue was dissolved in water (3 mL) and purified by semi-preparative HPLC using gradient II (flow rate 3.0 mL/min). The fractions were immediately frozen after collection. Nucleoside (S)-4 (7.5 mg, 37 %) was obtained as a white solid. The purity of the product was judged to be > 99 % by HPLC (gradient I or II, 8, 171.8, 169.5, 156.6, 151.6, 150.3, 135.5, 116.8, 87.6, 82.5, 70.9, 61.8, 51.9, 51.7, 49.6, 39.6, 38.2, 30.5, 28.5, 22.7, 22.2, 19.4 . 8, 171.9, 169.5, 156.8, 151.7, 150.3, 135.8, 117.3, 87.7, 82.7, 71.0, 61.8, 51.9, 51.7, 49.7, 39.6, 38.3, 30.5, 28.5, 22.7, 22.2, 19 .3. 
N2-acetyl-N6-[N-((9H-fluoren-9-ylmethyloxy)carbonyl)-L-[
Methyl N2-acetyl-N6-[N-(6,9-dihydro-6-oxo-9[2-deoxy-β-D-2-erythro-pentofuranosyl)-1H-
purin-2-yl)-L-alanyl]-L-lysine ((S)-4). A solution of (S)-
Methyl
N2-acetyl-N6-[N-(6,9-dihydro-6-oxo-9[2-deoxy-β-D-2-erythro-pentofuranosyl)-1H-purin-2-yl)-
L-alanyl]-L-lysine ((S)-1).
A solution of (S)-4 (7.25 mg, 0.0138 mmol) was stirred in an aqueous solution of LiOH (150 mM) and THF (750 µL, 1:2.5 v/v) for 2 h at room temperature. The reaction was monitored by analytical HPLC using gradient II and 100 mM ammonium formate and CH 3 CN as mobile S9 phase. When (S)-4 was no longer detectable, the mixture was concentrated under high vacuum using a centrifugal evaporator, then neutralized and very carefully acidified to pH 5.5 with 5 % acetic acid.
Purification was achieved by solid phase extraction (Phenomenex Strata-X 33µ 200 mg/3 mL), starting with 0.1 % formic acid, then 5 % MeOH, and 100 % MeOH. The desired compound eluted in the 100 % MeOH fraction, which was concentrated under high vacuum using a centrifugal evaporator. The residue was dissolved in water (3 mL) and lyophilized to afforded (S)-1 37 (6.0 mg, 85 %) as a white solid. 156.6, 151.6, 150.3, 135.5, 116.8, 87.7, 82.5, 70.9, 61.8, 51.8, 49.6, 40.0, 38.3, 30.7, 28.6, 22.8, 22.4, 19 .4.
N2-acetyl-N6-[N-(6,9-dihydro-6-oxo-9[2-deoxy-β-D-2-erythro-pentofuranosyl)-1H-purin-2-yl)-
D-alanyl]-L-lysine ((R)-1).
Following the procedure described above for (S)-1, alkaline hydrolysis of (R)-4 afforded (R)-1 37 in 84 % yield after purification by solid phase extraction. was added in portions (0.0015 mmol every 2 hr.) over 5 days (7 additions per day); the reaction was stirred at 37 °C for 2 additional days after the addition was complete and monitored by HPLC (gradient An authentic standard of (R)-CE-dGuo was prepared as previously described for comparison. 38 A sample of (R)-CE-dGuo was dissolved in deuterated phosphate buffer (pH 7.4, 100 mM) and incubated S12 at 37° C over 7 days in an NMR tube. No exchange of the proton between the N 2 and carboxylate groups was observed.
N2-acetyl-N6-[N-(6,9-dihydro-6-oxo-9[2-deoxy-β-D-2-erythro-pentofuranosyl)-1H-purin-2-yl)-
Formation of cross-link 1 in deuterated buffer. A dGuo (14.70 mg, 0.0515 mmol) solution in deuterated phosphate buffer (2.5 mL, 100 mM, pH 7.4) was prepared as described above. N-AcLys (38.68 mg, 205 mmol) then added and the reaction incubated 37° C. Methylglyoxal was added to the reaction in portions (0.0015 mmol every 2 h) over 4 days and the reaction was incubated at 37° C for an additional day after the methylglyoxal addition was complete. The reaction mixture was lyophilized and the solid residue dissolved in H 2 O (750 µL). The pH was carefully adjusted to 6.0 with 1% NaOH and the mixture purified by Phenomenex, Strata-X 33u Polymeric Reversed Phase (200 mg/3mL and 100 mg/3mL) solid-phase extraction (SPE) cartridge. The product was sequentially eluted with water (5 mL), 5% MeOH (5 mL), then 100% MeOH (7 mL) and the fractions were monitored by HPLC (gradient II, 100 mM HCOONH 4 /MeOH, flow rate 1.0 mL min -1 ). Methanol was removed in vacuo using a centrifugal evaporator. The residue was dissolved in water and purified by semi-preparative HPLC using gradient IV (100 mM HCOONH 4 /CH 3 CN, flow rate 2.5 mL min -acetyl-N6-[N-(6,9-dihydro-6-oxo- 
(S)-4 S18 Figure S6 . 1 H (top) and 13 C (bottom) NMR spectra (DMSO-d 6 ) of methyl N2 -acetyl-N6-[N-(6,9-dihydro-6-oxo- -acetyl-N6-[N-(6,9-dihydro-6-oxo-9-[2-deoxy- 
(S)-1 S22 Figure S10 . 1 H (top) and 13 C (bottom) NMR spectra of N2 -acetyl-N6-[N-(6,9-dihydro-6-oxo-9 -
(R)-1 Figure S11 . 1 H (top) and 13 C (bottom) NMR spectra (DMSO-d 6 ) of N2 -acetyl-N6-[N-(6,9-dihydro-6-oxo-9-[2-deoxy- -acetyl-N6-[N-(6,9-dihydro-6-oxo-9-[2-deoxy- . 1 H NMR spectra of (R)-and (S)-CE-dGuo adducts (D 2 O) synthesized from the reaction dGuo and glyceraldehyde as previously described. (Liebigs Ann. Chem., (1994), 851-853) .
A.
B. Figure S18 (con't) . UPLC-ESI-MS-SRM (-116 Da) chromatogram and ms 3 product ion spectrum of cross-links (R)-1 and (S)-1. 
